Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
33.04
-2.84 (-7.92%)
At close: Sep 18, 2026, 4:00 PM EDT
33.05
+0.01 (0.03%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.74 billion as of September 18, 2026. Its market cap has increased by 236.14% in one year.
Market Cap
1.74B
Enterprise Value
1.79B
1-Year Change
236.14%
Ranking
Category
Stock Price
$33.04
ChartMarket Cap Chart
Since the IPO on December 11, 2020, Nanobiotix's market cap has increased from $549.07M to $1.74B, an increase of 216.89%. That is a compound annual growth rate of 22.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.74B | 57.08% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xencor | 1.84B |
| Stoke Therapeutics | 1.83B |
| Maravai LifeSciences Holdings | 1.81B |
| Septerna | 1.81B |
| Vir Biotechnology | 1.79B |
| Tyra Biosciences | 1.77B |
| Intellia Therapeutics | 1.70B |
| Novavax | 1.67B |